{"id":"https://openalex.org/W2021668065","doi":"https://doi.org/10.1007/s40256-013-0037-0","title":"Role of Colesevelam in Combination Lipid-Lowering Therapy","display_name":"Role of Colesevelam in Combination Lipid-Lowering Therapy","alternate_titles":[],"publication_year":2013,"publication_date":"2013-08-03","ids":{"openalex":"https://openalex.org/W2021668065","doi":"https://doi.org/10.1007/s40256-013-0037-0","mag":"2021668065","pmid":"https://pubmed.ncbi.nlm.nih.gov/23913404","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3781306"},"language":"en","primary_location":{"id":"doi:10.1007/s40256-013-0037-0","doi":"https://doi.org/10.1007/s40256-013-0037-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40256-013-0037-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40256-013-0037-0.pdf","source":{"id":"https://openalex.org/S151621711","display_name":"American Journal of Cardiovascular Drugs","issn_l":"1175-3277","issn":["1175-3277","1179-187X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Cardiovascular Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2021668065"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40256-013-0037-0.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103476905","display_name":"Michael R. Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael R. Jones","raw_affiliation_strings":[", Port St. Lucie, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", Port St. Lucie, FL, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009294113","display_name":"Oliseyenum M. Nwose","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]},{"id":"https://openalex.org/I4210162815","display_name":"Daiichi Sankyo (United States)","ror":"https://ror.org/055werx92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210104626","https://openalex.org/I4210162815"]}],"countries":["JP","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Oliseyenum M. Nwose","raw_affiliation_strings":["Daiichi Sankyo, Inc., 2 Hilton Court, Parsippany, NJ, 07054, USA","Daiichi-Sankyo, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daiichi Sankyo, Inc., 2 Hilton Court, Parsippany, NJ, 07054, USA","institution_ids":["https://openalex.org/I4210162815"]},{"raw_affiliation_string":"Daiichi-Sankyo, Inc","institution_ids":["https://openalex.org/I4210104626"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5009294113"],"corresponding_institution_ids":["https://openalex.org/I4210104626","https://openalex.org/I4210162815"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":{"value":4790,"currency":"USD","value_usd":4790},"fwci":0.4939,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.47064083,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"13","issue":"5","first_page":"315","last_page":"323"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/colesevelam","display_name":"colesevelam","score":1.0},{"id":"https://openalex.org/keywords/bile-acid-sequestrants","display_name":"bile acid sequestrants","score":0.9900000095367432},{"id":"https://openalex.org/keywords/combination-lipid-lowering-therapy","display_name":"combination lipid-lowering therapy","score":0.9399999976158142},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.8379999995231628},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8059999942779541},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.9509999752044678},{"id":"https://openalex.org/keywords/niacin","display_name":"nicotinic acid","score":0.8610000014305115},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.9959999918937683},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.8949999809265137},{"id":"https://openalex.org/keywords/apolipoprotein-a-i","display_name":"apolipoprotein A-I","score":0.9300000071525574},{"id":"https://openalex.org/keywords/high-sensitivity-c-reactive-protein","display_name":"high-sensitivity C-reactive protein","score":0.9459999799728394},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9269999861717224},{"id":"https://openalex.org/keywords/statin-induced-diabetes","display_name":"statin-induced diabetes","score":0.7250000238418579},{"id":"https://openalex.org/keywords/statin-induced-myopathy","display_name":"statin-induced myopathy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8180000185966492},{"id":"https://openalex.org/keywords/impaired-glucose-tolerance","display_name":"impaired glucose tolerance","score":0.7689999938011169},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8640000224113464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8608784675598145},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.7859494686126709},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4564802944660187},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4469178318977356},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3646792471408844},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30393433570861816}],"mesh":[{"descriptor_ui":"D000069472","descriptor_name":"Colesevelam Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000499","descriptor_name":"Allylamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000499","descriptor_name":"Allylamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000499","descriptor_name":"Allylamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000499","descriptor_name":"Allylamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1007/s40256-013-0037-0","doi":"https://doi.org/10.1007/s40256-013-0037-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40256-013-0037-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40256-013-0037-0.pdf","source":{"id":"https://openalex.org/S151621711","display_name":"American Journal of Cardiovascular Drugs","issn_l":"1175-3277","issn":["1175-3277","1179-187X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Cardiovascular Drugs","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2772444","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3781306","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3781306","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3781306/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Am J Cardiovasc Drugs","raw_type":"Text"},{"id":"pmid:23913404","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23913404","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of cardiovascular drugs : drugs, devices, and other interventions","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.771.2373","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.771.2373","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/ee/70/40256_2013_Article_37.PMC3781306.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1007/s40256-013-0037-0","doi":"https://doi.org/10.1007/s40256-013-0037-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40256-013-0037-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40256-013-0037-0.pdf","source":{"id":"https://openalex.org/S151621711","display_name":"American Journal of Cardiovascular Drugs","issn_l":"1175-3277","issn":["1175-3277","1179-187X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Cardiovascular Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2021668065.pdf","grobid_xml":"https://content.openalex.org/works/W2021668065.grobid-xml"},"referenced_works_count":74,"referenced_works":["https://openalex.org/W34443605","https://openalex.org/W159298319","https://openalex.org/W1523152575","https://openalex.org/W1587435290","https://openalex.org/W1587888282","https://openalex.org/W1591834330","https://openalex.org/W1963958736","https://openalex.org/W1965975466","https://openalex.org/W1966442514","https://openalex.org/W1966936568","https://openalex.org/W1970771772","https://openalex.org/W1971627211","https://openalex.org/W1972661406","https://openalex.org/W1974882957","https://openalex.org/W1977208802","https://openalex.org/W1993796214","https://openalex.org/W1994316655","https://openalex.org/W1998939122","https://openalex.org/W2001774934","https://openalex.org/W2004549247","https://openalex.org/W2007861083","https://openalex.org/W2009674945","https://openalex.org/W2012345406","https://openalex.org/W2012952446","https://openalex.org/W2016598185","https://openalex.org/W2016622896","https://openalex.org/W2025422355","https://openalex.org/W2036303969","https://openalex.org/W2046189497","https://openalex.org/W2055835176","https://openalex.org/W2061611908","https://openalex.org/W2067046315","https://openalex.org/W2071802081","https://openalex.org/W2072946847","https://openalex.org/W2074516883","https://openalex.org/W2076565086","https://openalex.org/W2083270733","https://openalex.org/W2085737093","https://openalex.org/W2085942677","https://openalex.org/W2093260782","https://openalex.org/W2093866061","https://openalex.org/W2103108681","https://openalex.org/W2106343349","https://openalex.org/W2111099202","https://openalex.org/W2115169717","https://openalex.org/W2118184073","https://openalex.org/W2129875389","https://openalex.org/W2130771193","https://openalex.org/W2138109132","https://openalex.org/W2139353545","https://openalex.org/W2140072878","https://openalex.org/W2142264046","https://openalex.org/W2143465004","https://openalex.org/W2144577176","https://openalex.org/W2145146113","https://openalex.org/W2147133240","https://openalex.org/W2151349993","https://openalex.org/W2153303712","https://openalex.org/W2153535950","https://openalex.org/W2155243965","https://openalex.org/W2155598961","https://openalex.org/W2158474131","https://openalex.org/W2163547584","https://openalex.org/W2165605025","https://openalex.org/W2165688246","https://openalex.org/W2321230622","https://openalex.org/W2477872031","https://openalex.org/W2510708214","https://openalex.org/W4213225455","https://openalex.org/W4230285830","https://openalex.org/W4230870013","https://openalex.org/W4246764494","https://openalex.org/W4254363271","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2062086873","https://openalex.org/W4291513501","https://openalex.org/W1998297785","https://openalex.org/W2085737093","https://openalex.org/W1973224273","https://openalex.org/W2043614996","https://openalex.org/W2032035573","https://openalex.org/W2071802081"],"abstract_inverted_index":{"Hyperlipidemia":[0],"is":[1,155,325],"associated":[2],"with":[3,80,144,175,185,202,212,260,270,291,312,344,354,391],"an":[4],"increased":[5],"risk":[6,23,119,127],"of":[7,35,58,65,73,86,120,148,152,166,208,274,285,375,404,413],"cardiovascular":[8],"events;":[9],"reducing":[10,54],"low-density":[11],"lipoprotein":[12],"cholesterol":[13],"(LDL-C),":[14],"the":[15,22,32,161,164,271,281,319,332,355,373,400],"primary":[16],"target":[17],"for":[18,24,53,128,135,339],"cholesterol-lowering":[19,385],"therapy,":[20],"lowers":[21],"such":[25,315],"events.":[26,322],"Although":[27],"bile":[28,170],"acid":[29,171],"sequestrants":[30],"were":[31],"first":[33],"class":[34],"drugs":[36,138,215,357],"to":[37,43,96,100,139,156,305,351],"show":[38],"a":[39,70,110,133,168,336],"mortality":[40],"benefit":[41],"related":[42],"LDL-C":[44,55,78,199],"lowering,":[45],"statins":[46,116,248,286],"are":[47],"now":[48],"considered":[49],"first-line":[50],"pharmacological":[51],"therapy":[52,103],"levels":[56,252],"because":[57,85],"their":[59,62],"potency":[60],"and":[61,189,233,239,268,277,287,328,359],"remarkable":[63],"record":[64],"successful":[66],"outcomes":[67],"studies.":[68],"Nevertheless,":[69],"substantial":[71],"proportion":[72],"patients":[74,92,124],"do":[75],"not":[76,108,326,352],"achieve":[77],"goals":[79],"statin":[81,102,113,226,230,265],"monotherapy.":[82],"In":[83],"addition,":[84],"adverse":[87,321],"effects":[88,207,284,314,386,412],"(primarily":[89],"myopathy),":[90],"some":[91,192,397],"may":[93,107,117,363,406],"be":[94,140,364,407],"unwilling":[95],"use":[97,165],"or":[98,106,145,229,247,264,294],"unable":[99],"tolerate":[101,109],"at":[104,125],"all":[105,203],"full":[111],"therapeutic":[112],"dose.":[114],"Also,":[115],"increase":[118],"new-onset":[121],"diabetes":[122],"in":[123,142,146,173,183,198,210,218,241,289,309,331,389,396,409],"high":[126],"diabetes.":[129],"Thus,":[130],"there":[131],"remains":[132],"need":[134],"other":[136,176,213,306,345,392,414],"lipid-lowering":[137,177,214,307,356,393,415],"used":[141,388],"combination":[143,174,184,211,273,390],"place":[147],"statins.":[149],"The":[150],"purpose":[151],"this":[153],"article":[154],"review":[157],"available":[158],"data":[159,379],"from":[160],"literature":[162],"on":[163],"colesevelam,":[167,275],"second-generation":[169],"sequestrant,":[172],"agents.":[178],"Colesevelam":[179,279,298,347],"has":[180,335,348,383],"been":[181,349],"studied":[182],"statins,":[186,223,245,261],"niacin,":[187,228],"fibrates,":[188,224,262],"ezetimibe":[190],"(including":[191],"three-drug":[193],"combinations).":[194],"An":[195],"additive":[196,384],"reduction":[197],"was":[200,258,299],"seen":[201],"combinations.":[204],"Other":[205],"observed":[206],"colesevelam":[209,257,324,382,405],"include":[216],"reductions":[217],"apolipoprotein":[219],"(apo)":[220],"B":[221],"(with":[222,237,244],"ezetimibe,":[225,246,263,267],"plus":[227,231,249,266],"ezetimibe)":[232],"high-sensitivity":[234],"C-reactive":[235],"protein":[236],"statins),":[238],"increases":[240],"apo":[242],"A-I":[243],"niacin).":[250],"Triglyceride":[251],"remained":[253],"relatively":[254],"unchanged":[255],"when":[256,303,387],"combined":[259],"decreased":[269],"triple":[272],"statin,":[276],"niacin.":[278],"offset":[280],"negative":[282],"glycemic":[283],"niacin":[288],"subjects":[290],"insulin":[292],"resistance":[293],"impaired":[295],"glucose":[296],"tolerance.":[297],"generally":[300],"well":[301],"tolerated":[302],"added":[304],"therapies":[308],"clinical":[310],"trials,":[311],"gastrointestinal":[313],"as":[316],"constipation":[317],"being":[318],"predominant":[320],"Since":[323],"absorbed":[327],"works":[329],"primarily":[330],"intestine,":[333],"it":[334],"low":[337],"potential":[338],"systemic":[340],"metabolic":[341],"drug-drug":[342],"interactions":[343],"drugs.":[346,416],"shown":[350],"interact":[353],"lovastatin":[358],"fenofibrate;":[360],"where":[361],"interaction":[362],"anticipated,":[365],"separating":[366],"dosing":[367],"times":[368],"by":[369],"4":[370],"h":[371],"reduces":[372],"impact":[374],"any":[376],"interaction.":[377],"Available":[378],"confirms":[380],"that":[381],"therapies.":[394],"Furthermore,":[395],"patient":[398],"populations,":[399],"additional":[401],"glucose-lowering":[402],"effect":[403],"beneficial":[408],"offsetting":[410],"hyperglycemic":[411]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2021668065","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2014,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
